FDA Approves New Treatment Option for Breast Cancer
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
While COVID-19 is at the center of medical news, important cancer research findings continue to be reported. As March...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
As we keep an eye out for those promised May flowers, we bring you the latest round of Editors’...
Back for the month of October are the editors’ picks from the eight esteemed scientific journals published by the...
Every month, the editors from the portfolio of scientific journals published by the AACR select one “must read” article...
As we finally welcome spring, enjoy this hand-picked selection of articles brought to you by the editors of the...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Among the studies published during the month of October in the nine AACR journals, the editors have chosen to highlight results from two clinical trials of DNA...
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...
The signature pink ribbons of Breast Cancer Awareness Month have become almost as much a part of October as...
January is Cervical Cancer Awareness Month. Given that January was named after the Roman god Janus, whose two faces...
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...
As the candy supply dwindles, and the Halloween sugar rush tapers off, get re-energized by the latest edition of...
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
As we head into summer, enjoy this month’s selection of studies spotlighted by the editors of the 10 AACR...
The prognosis for a patient with cancer depends on several factors, including the cancer’s stage. Patients whose cancers are diagnosed at earlier...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...
Cancer researchers and cancer survivors are often viewed in separate silos. Scientists toil away alone in laboratories to decode the mechanisms of the disease and test novel molecules. Cancer...
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the antibody–drug conjugate brentuximab vedotin (Adcetris)...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
As a predoctoral student in the Integrated Biomedical Sciences Graduate Program at The Ohio State University in 2005, Bethany...
You’re feeling sluggish. You eat a banana. You feel better. We all know that a calorie-rich snack can provide...
Thirty years ago, Mary-Claire King, PhD, FAACR, and colleagues were the first to demonstrate that breast cancer could be genetically inherited....